Therapy with cytokines and biological response modifiers brms prior to syngeneic bone marrow transplantation in mice effect of recombinant human interleukin 1 beta rhil 1 beta interleukin 2 rhil 2 interleukin 6 rhil 6 recombinant murine tumor necrosis factor alpha rmtnf alpha and chinese herbal medicine ninjin youei to nyt on immunohematologic reconstitution
Fujii, Y.; Imamura, M.; Hashino, S.; Kobayashi, H.; Kobayashi, M.; Kasai, M.; Sakurada, K.; Miyazaki, T.
Biomedicine and Pharmacotherapy 46(5-7): 315
1992
ISSN/ISBN: 0753-3322 Accession: 033983916
PDF emailed within 1 workday: $29.90
Related References
Clutterbuck, E.J.; Sanderson, C.J. 1990: Regulation of human eosinophil precursor production by cytokines: a comparison of recombinant human interleukin-1 (rhIL-1), rhIL-3, rhIL-5, rhIL-6, and rh granulocyte-macrophage colony-stimulating factor Blood 75(9): 1774-1779Fujii, Y.; Imamura, M.; Hashino, S.; Kobayashi, H.; Kobayashi, M.; Sakurada, K.; Miyazaki, T.; Hori, K. 1991: Effects of recombinant human interleukin 1 beta recombinant human interleukin 2 and recombinant murine tumor necrosis factor alpha on the reconstitution of hematopoiesis and immune functions in lethally irradiated mice transplanted with syngeneic bone marrow cells Miyazaki, T , F Takaku And H Uchino (Ed ) International Congress Series, 956 Myelodysplastic Syndrome And Cytokines; International Symposium, Sapporo, Japan, September 28-29, 1990 Xii+325p Elsevier Science Publishers B V : Amsterdam, Netherlands; (Dist in The Usa And Canada By Elsevier Science Publishing Co , Inc : New York, New York) Illus 191-194
Modi M.; Nadeau R.; Ni Wu G.; Della Valle C.; Olejnik N.; Hayes T.; Liberato D. 1991: The pharmacokinetics of recombinant human interleukin 1 alpha rhil 1 alpha in rats that received single ascending intravenous doses of rhil 1 alpha and the resultant dose dependent concentrations of endogenous serum interleukin 6 il 6 FASEB Journal 5(6): A1567
Aoki, I.; Homori, M.; Nakahara, K.; Higashi, K.; Ishikawa, K. 1995: Effects of rhIL-1 alpha, rhIL-1 beta, and rhIL-1 receptor antagonist on erythroid progenitors (CFU-E and BFU-E) in human bone marrow Experimental Hematology 23(3): 217-225
Nemunaitis, J.; Ross, M.; Meisenberg, B.; O'Reilly, R.; Lilleby, K.; Buckner, C.D.; Appelbaum, F.R.; Buhles, W.; Singer, J.; Peters, W.P. 1994: Phase i study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failure Bone Marrow Transplantation 14(4): 583-588
Mumcuoglu, M.; Slavin, S. 1999: Enhancement of hematopoietic reconstitution with recombinant cytokines: effect of rhIL-6 in combination with rhGM-CSF and rhIL-3 on unmodified or T cell-depleted bone marrow Journal of HematoTherapy 8(3): 247-253
Winton, E.F.; Srinivasiah, J.; Kim, B.K.; Hillyer, C.D.; Strobert, E.A.; Orkin, J.L.; Swenson, R.B.; McClure, H.M.; Myers, L.A.; Saral, R. 1994: Effect of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on hematopoietic regeneration as demonstrated in a nonhuman primate chemotherapy model Blood 84(1): 65-73
Chelstrom, L.M.; Finnegan, D.; Uckun, F.M. 1992: Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines. Comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF alpha), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), and their combination Leukemia and Lymphoma 7(1-2): 79-86
Chelstrom, L.M.; Finnegan, D.; Uckun, F.M. 1992: Treatment of bcl 1 murine b cell leukemia with recombinant cytokines comparative analysis of the anti leukemic potential of interleukin 1 beta il 1 beta interleukin 2 il 2 interleukin 6 il 6 tumor necrosis factor alpha tnfalpha granulocyte colony stimulant factor g csf granulocyte macrophage colony stimulating factor gm csf and their combination Leukemia and Lymphoma 7(1-2): 79-86
Miller, D.J.; Norman, D.C.; Yoshikawa, T.T.; Hahn, T.J. 1992: Effect of age on fever response to recombinant tumor necrosis factor alpha rtnfalpha recombinant interleukin one alpha ril 1 alpha and recombinant interleukin six ril 6 in a murine model Clinical Research 40(2): 195A
Orazi, A.; Cooper, R.J.; Tong, J.; Gordon, M.S.; Battiato, L.; Sledge, G.W.; Kaye, J.A.; Kahsai, M.; Hoffman, R. 1996: Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow Experimental Hematology 24(11): 1289-1297
Marks, T.A.; Tracy, D.E. 1995: Prevention of human recombinant interleukin-1 beta (rhIL-1 beta) embryolethality with progesterone or indomethacin American Journal of Reproductive Immunology 33(4): 292-300
Iigo, M.; Nishikata, K.; Hoshi, A. 1990: Effect of recombinant interleukin-1 alpha, recombinant interleukin-2, recombinant interferon-beta, and recombinant tumor necrosis factor on subcutaneously implanted adenocarcinoma 755 and Lewis lung carcinoma Journal of Biological Response Modifiers 9(4): 426-430
Nemunaitis, J.; Ross, M.; Meisenberg, B.; Oreilly, R.; Lilleby, K.; Buckner, C.D.; Appelbaum, F.R.; Buhles, W.; Singer, J.; Peters, W.P. 1994: Phase I study of recombinant human interleukin-1β (rhIL-1β) in patients with bone marrow failure Bone Marrow Transplantation (Basingstoke) 14(4): 583-588
Butler, D.M.; Vitti, G.F.; Leizer, T.; Hamilton, J.A. 1988: Stimulation of the hyaluronic acid levels of human synovial fibroblasts by recombinant human tumor necrosis factor alpha, tumor necrosis factor beta (lymphotoxin), interleukin-1 alpha, and interleukin-1 beta Arthritis and Rheumatism 31(10): 1281-1289
Czuprynski, C.J.; Haak-Frendscho, M.; Maroushek, N.; Brown, J.F. 1992: Effects of recombinant human interleukin-6 alone and in combination with recombinant interleukin-1 alpha and tumor necrosis factor alpha on antibacterial resistance in mice Antimicrobial Agents and ChemoTherapy 36(1): 68-70
Evans, D.B.; Bunning, R.A.D.; Russell, R.G.G. 1990: The effects of recombinant human interleukin 1 beta rhil 1 beta on human osteoblast like cells in vitro Calcified Tissue International 46(Suppl 2): A34
Numerof, R.P.; Dinarello, C.A.; Endres, S.; Lonnemann, G.; Van Der Meer, J.W.M.; Mier, J.W. 1987: Interleukin 2 il 2 stimulates the production of interleukin 1 beta il 1 beta interleukin 1 alpha il 1 alpha and tumor necrosis factor alpha tnf alpha from human peripheral blood mononuclear cells pbmc Journal of Leukocyte Biology 42(5): 545
Nemunaitis, J.; Singer, J.W. 1989: The effect of recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and recombinant human interleukin-1 (rhIL-1) on proliferation of human tumor cell lines Cancer Journal (Villejuif) 2(11): 369-372
Rinehart, J.; Hersh, E.; Issell, B.; Triozzi, P.; Buhles, W.; Neidhart, J. 1997: Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940 Cancer Investigation 15(5): 403-410